Clinical Trials Browser

OTHER_GOV × Interventional × Hodgkin Disease × Clear all

Graft vs Host Disease, Hodgkin Disease, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02389101 2019-08-05

MILY

Phase NA Completed

21 enrolled 3 charts

Lymphoid

Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin

NCT01079013 2016-04-20

Treosulfan-based Conditioning for Allogeneic Stem-cell Transplantation (SCT) in Lymphoid Malignancies

Phase 2 Unknown

40 enrolled

Lymphoid

Hodgkin Disease, Lymphoma, Non-Hodgkin

NCT02507479 2016-04-20

Thiotepa-based Conditioning for Allogeneic Stem-cell Transplantation (SCT) in Lymphoid Malignancies

Phase 2 Unknown

24 enrolled

LymphoidOther hematologic neoplasmPlasma cell

Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell

NCT00163748 2016-01-08

Efficacy and Treatment Related Toxicity Study of a New Regimen for Lymphoma

Phase 2 Completed

40 enrolled

Lymphoid

Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin

NCT00163761 2016-01-08

Efficacy Study of Outpatient Therapy for Lymphoma

Phase 2 Completed

90 enrolled

Lymphoid

Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin

NCT01164345 2015-12-03

Mozobil for Autologous Stem Cell Mobilization

Phase 2 Completed

20 enrolled

Lymphoid

Hodgkin Disease, Lymphoma, Non-Hodgkin

NCT02145923 2015-06-10

Effectiveness and Safety of MMSCs for Enhancing Hematopoietic Recovery and Prophylaxis of Neutropenic Enterocolitis

Phase 1/2 Unknown

16 enrolled

Classical hematologyLymphoid

Anemia, Aplastic, Hodgkin Disease, Enterocolitis, Neutropenic

NCT01300156 2011-02-21

Etoposide, Methylprednisolone, High-dose Cytarabine and Oxaliplatin (ESHAOx) for Refractory or Relapsed Hodgkin's Lymphoma (HL)

Phase 2 Unknown

37 enrolled

Lymphoid

Hodgkin Disease, Lymphoma, Recurrence

Clinical Trials

PTCy and ATG for MSD and MUD Transplants

MILY

Treosulfan-based Conditioning for Allogeneic Stem-cell Transplantation (SCT) in Lymphoid Malignancies

Thiotepa-based Conditioning for Allogeneic Stem-cell Transplantation (SCT) in Lymphoid Malignancies

Efficacy and Treatment Related Toxicity Study of a New Regimen for Lymphoma

Efficacy Study of Outpatient Therapy for Lymphoma

Mozobil for Autologous Stem Cell Mobilization

Effectiveness and Safety of MMSCs for Enhancing Hematopoietic Recovery and Prophylaxis of Neutropenic Enterocolitis

Etoposide, Methylprednisolone, High-dose Cytarabine and Oxaliplatin (ESHAOx) for Refractory or Relapsed Hodgkin's Lymphoma (HL)